156 related articles for article (PubMed ID: 22753830)
1. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly.
Boersma WG
Eur Respir J; 2012 Jul; 40(1):1-3. PubMed ID: 22753830
[No Abstract] [Full Text] [Related]
2. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Sethi S
Eur Respir J; 2012 Jul; 40(1):17-27. PubMed ID: 22135277
[TBL] [Abstract][Full Text] [Related]
3. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Faragó G; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2011; 6():373-83. PubMed ID: 21760724
[TBL] [Abstract][Full Text] [Related]
4. No more equivalence trials for antibiotics in exacerbations of COPD, please.
Miravitlles M; Torres A
Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
[No Abstract] [Full Text] [Related]
5. [Gigantic study planned. 100,000 patients with COPD test general practice antibiotic].
MMW Fortschr Med; 2004 Mar; 146(10):41. PubMed ID: 15347081
[No Abstract] [Full Text] [Related]
6. Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease.
Miravitlles M; García-Polo C; Domenech A; Villegas G; Conget F; de la Roza C
Lung; 2013 Oct; 191(5):523-30. PubMed ID: 23842641
[TBL] [Abstract][Full Text] [Related]
7. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.
Portier H; Brambilla C; Garre M; Paganin F; Poubeau P; Zuck P
Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):367-76. PubMed ID: 15944847
[TBL] [Abstract][Full Text] [Related]
9. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Lipsky BA; Giordano P; Choudhri S; Song J
J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
[TBL] [Abstract][Full Text] [Related]
10. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Wilson R; Macklin-Doherty A
Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis.
Arrieta JR; Galgano AS; Sakano E; Fonseca X; Amábile-Cuevas CF; Hernández-Oliva G; Vivar R; González G; Torres A;
Am J Otolaryngol; 2007; 28(2):78-82. PubMed ID: 17362810
[TBL] [Abstract][Full Text] [Related]
12. PURLs: Should you consider antibiotics for exacerbations of mild COPD?
Nissly T; Prasad S
J Fam Pract; 2014 Apr; 63(4):E11-3. PubMed ID: 24905129
[TBL] [Abstract][Full Text] [Related]
13. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
14. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.
Cuevas O; Oteo J; Lázaro E; Aracil B; de Abajo F; García-Cobos S; Ortega A; Campos J;
J Antimicrob Chemother; 2011 Mar; 66(3):664-9. PubMed ID: 21172788
[TBL] [Abstract][Full Text] [Related]
15. More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all?
Llor C; Miravitlles M
Clin Microbiol Infect; 2007 Jul; 13(7):748-9. PubMed ID: 17501972
[No Abstract] [Full Text] [Related]
16. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Iudina LV; Snezhko VI; Rachko IuV
Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics in acute exacerbations of chronic obstructive pulmonary disease.
McIvor RA
Can Fam Physician; 2009 Jan; 55(1):15-6, 19-21. PubMed ID: 19155354
[No Abstract] [Full Text] [Related]
19. Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.
Brusse-Keizer M; VanderValk P; van der Zanden RW; Nijdam L; van der Palen J; Hendrix R; Movig K
Int J Chron Obstruct Pulmon Dis; 2015; 10():455-61. PubMed ID: 25767383
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Llor C; Naberan K; Cots JM; Molina J; Miravitlles M
Int J Clin Pract; 2004 Oct; 58(10):937-44. PubMed ID: 15587773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
